Abbott has initiated a medical device correction for sensors used in certain FreeStyle Libre 3 continuous glucose monitoring (CGM) systems in the US after determining that a number of them may be ...
A company spokesperson told Fierce Medtech that Abbott estimates the issue will affect less than 1% of FreeStyle Libre 3 users in the U.S. (Abbott) Abbott is asking users of its FreeStyle Libre 3 ...
The FDA has updated some information about the December recall of certain Abbott FreeStyle Libre 3 and 3 Plus glucose sensors. In December 2025, FDA posted an early alert that Abbott Diabetes Care was ...
Sensor-based CGM systems like Abbott’s are designed to provide blood sugar readings without requiring users to perform regular fingersticks. (Abbott) Nearly two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results